Global Cord Blood (CORBF) seeks court approval of third provisional liquidator fee period
Rhea-AI Filing Summary
Global Cord Blood Corporation, which is in provisional liquidation under the supervision of the Grand Court of the Cayman Islands, provided an update on the process to approve fees of the Joint Provisional Liquidators (JPLs). The JPLs have already obtained Court approval of their remuneration and disbursements for two prior periods covering 22 September 2022 to 30 September 2024.
They are now seeking Court sanction of their fees and disbursements for the Third Fee Approval Period, from 1 October 2024 to 30 September 2025, detailed in a Third Fee Report dated 6 August 2026. Because of an ongoing dispute over the Company’s register of members and prior inquorate extraordinary general meetings, the JPLs intend to ask the Court to dispense with the requirement to hold a shareholders’ meeting for this period.
Shareholders may request a copy of the Third Fee Report by emailing evidence of their shareholding to the JPLs and may submit queries about the report by email by 28 August 2026.
Positive
- None.
Negative
- None.
Key Figures
Appointment of JPLs: 22 September 2022
Third Fee Approval Period: 1 October 2024 to 30 September 2025
Third Fee Report date: 6 August 2026
+3 more
6 metrics
Appointment of JPLs
22 September 2022
Date the Court appointed Joint Provisional Liquidators
Third Fee Approval Period
1 October 2024 to 30 September 2025
Period covered by the JPLs’ Third Fee Report
Third Fee Report date
6 August 2026
Date of the JPLs’ Third Fee Report
Shareholder enquiry deadline
28 August 2026
Deadline for shareholders to email enquiries on the Third Fee Report
First fee court approval date
13 November 2024
Court approval of fees for 22 September 2022 to 30 September 2023
Second fee court approval date
11 July 2025
Court approval of fees for 1 October 2023 to 30 September 2024
Key Terms
Joint Provisional Liquidators, extraordinary general meeting, register of members, Court sanction, +1 more
5 terms
Joint Provisional Liquidators regulatory
"appointing Margot MacInnis and John Royle ... as Joint Provisional Liquidators"
Joint provisional liquidators are temporary, court-appointed officials who take control of a troubled company's assets and affairs while a formal winding-up or insolvency process is being decided. Think of them as emergency guardians who stop value being lost, secure records, and assess whether creditors or shareholders can recover funds. Investors pay attention because their appointment usually signals serious financial distress, potential suspension of trading, and uncertainty about how much, if anything, will be repaid.
extraordinary general meeting regulatory
"convened an extraordinary general meeting (“EGM”) for 16 April 2024"
register of members regulatory
"ultimately as a result of a dispute concerning the Company’s register of members"
An official list maintained by a company that records who owns its shares, how many they own and their contact details, similar to a class roster or bank ledger for ownership. It matters to investors because only people on the list can vote at meetings, receive dividends or corporate communications, and it provides clear proof of ownership and helps enforce rights during share transfers or corporate actions.
Court sanction regulatory
"the JPLs’ intention to obtain Court sanction of the fees described therein"
in provisional liquidation regulatory
"Global Cord Blood Corporation (In Provisional Liquidation) (the “Company”)"
FAQ
What does Global Cord Blood (CORBF) report in this August 2026 Form 6-K?
Global Cord Blood reports that its Joint Provisional Liquidators are seeking Court sanction of their fees for the period 1 October 2024 to 30 September 2025, and describes how shareholders can access the detailed Third Fee Report and raise questions.
What is the Third Fee Approval Period for Global Cord Blood (CORBF)?
The Third Fee Approval Period covers the JPLs’ remuneration and disbursements from 1 October 2024 to 30 September 2025. These fees are summarized in a Third Fee Report dated 6 August 2026, which the JPLs plan to submit to the Court for approval.
Why is Global Cord Blood (CORBF) not holding an EGM for the third fee approval?
The JPLs state they intend to ask the Court to dispense with an EGM for the Third Fee Approval Period. They cite an ongoing dispute over the register of members and prior inquorate EGMs, and aim to avoid additional meeting costs.
What prior fee approvals for CORBF’s JPLs has the Court granted?
The Court approved the JPLs’ remuneration and disbursements for 22 September 2022 to 30 September 2023 on 13 November 2024, and for 1 October 2023 to 30 September 2024 on 11 July 2025, with shareholders notified via earlier SEC filings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2026
Commission File Number: 001-34541
GLOBAL CORD BLOOD CORPORATION
(Translation of registrant’s name into English)
48th Floor, Bank of China Tower
1 Garden Road
Central
Hong Kong S.A.R.
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ⌧ Form 40-F ☐
Introductory Note
On September 22, 2022, the Grand Court of the Cayman Islands (the “Court”) issued an order appointing Margot MacInnis and John Royle of Grant Thornton Specialist
Services (Cayman) Limited, and Chow Tsz Nga Georgia of Grant Thornton Recovery & Reorganisation Limited, as joint provisional liquidators (the “JPLs”) of Global Cord Blood Corporation (the “Company”) pursuant to Section 104(2) of the Companies Act
(as amended) of the Cayman Islands.
Third Fee Report
On August 6, 2026, the JPLs issued their third fee report relating to fees and disbursements during the period October 1, 2024 to September 30, 2025. Attached to this report as Exhibit
99.1 is a letter dated August 6, 2026 to purported shareholders providing notice of the fee report, the JPLs’ intent to provide a copy to any shareholder who is able to evidence their holding, and the JPLs’ intention to obtain Court sanction of the
fees described therein.
EXHIBIT INDEX
|
Exhibit
|
Description
|
|
99.1
|
Letter to Shareholders
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
GLOBAL CORD BLOOD CORPORATION
|
|
|
|
|
|
|
|
By:
|
/s/ John Royle |
|
|
Name:
|
John Royle
|
|
|
Title:
|
Joint Provisional Liquidator by Order of the Grand Court of the Cayman Islands
|
Dated: August 12, 2026
Exhibit 99.1
Commercial in Confidence
|
To: All purported Shareholders of Global Cord Blood Corporation (In Provisional
Liquidation)
6 August 2026
Dear Shareholders,
|
Grant Thornton Specialist Services (Cayman) Limited
3rd floor Century Yard,
Cricket Square,
PO Box 765,
Grand Cayman, KY1-9006
Cayman Islands
T +1 (345) 949 7100
F +1 (345) 949 7120
|
Global Cord Blood Corporation (In Provisional Liquidation) (the “Company”)
Cause No: FSD 108 of 2022 (DDJ)
Cayman Islands company number: 227732
Introduction
On 22 September 2022, the Grand Court of the Cayman Islands (“Court”) issued an order (“Court Order”) appointing Margot MacInnis and John Royle of Grant Thornton Specialist Services (Cayman)
Limited, and Chow Tsz Nga Georgia of Grant Thornton Recovery & Reorganisation Limited, as Joint Provisional Liquidators (“JPLs”) of the Company pursuant to Section 104(2) of the Companies Act (as amended) of the Cayman Islands.
JPLs’ First Fee Approval Application
Pursuant to the powers granted by the Court Order and the Company’s constitutional documents, the Company (acting by its JPLs)
convened an extraordinary general meeting (“EGM”) for 16 April 2024 to consider ordinary resolutions to approve the JPLs’ fees and disbursements for the period 22 September 2022 to 30 September 2023 (“First Fee Approval Period”). The JPLs were unable to hold the EGM, or the subsequently adjourned EGM, as both were inquorate, ultimately as a result of a dispute concerning the Company’s register of members.
Notwithstanding this, the Court approved the JPLs’ remuneration and disbursements for the First Fee Approval Period on 13 November 2024, following an application by the JPLs.
JPLs’ Second Fee Approval Application
The JPLs’ fees and disbursements for the period 1 October 2023 to 30 September 2024 (“Second Fee
Approval Period”) were detailed in a report dated 10 February 2025. Following an application by the JPLs, the Court approved the JPLs’ remuneration and disbursements for the Second Fee Approval Period on 11 July 2025 and dispensed with the
requirement to convene an EGM. Shareholders were informed of these events by way of publications on the SEC platform, accessible here:
• https://www.sec.gov/Archives/edgar/data/1467808/000092963825000650/form6k.htm
• https://www.sec.gov/Archives/edgar/data/1467808/000092963825002127/form6k.htm
JPLs’ Third Fee Approval Application
The JPLs are taking steps to seek Court sanction of their fees and disbursements for the period 1 October 2024 to 30 September
2025 (“Third Fee Approval Period”), which have been detailed in a further report dated 6 August 2026 (“Third Fee Report”).
|
Grant Thornton Specialist Services (Cayman) Limited is a member firm of Grant Thornton International Ltd (GTIL) and a subsidiary of Grant Thornton UK Advisory & Tax LLP. GTIL and the
member firms are not a worldwide partnership. Services are delivered by the member firms. GTIL and its member firms are not agents of, and do not obligate, one another and are not liable for one another’s acts or omissions. Please see
grantthornton.ky for further details. Subject to local regulations.
|
grantthornton.ky
|
Commercial in Confidence
By virtue of the ongoing dispute as to the Company’s register of members, and to avoid the costs associated with convening an EGM (which the JPLs
expect would be inquorate), the JPLs intend to seek orders from the Court dispensing with the requirement to hold an EGM in respect of the Third Fee Approval Period.
Should any shareholder wish to receive a copy of the Third Fee Report, we request that documentary evidence of their shareholding be
submitted, together with their request, by email to GCBCJPLs@uk.gt.com.
The Third Fee Report provides shareholders with sufficient information to make an informed decision about the
reasonableness of the remuneration incurred during the Third Fee Approval Period. The report should be read in conjunction with the JPLs’ quarterly reports issued during the relevant period, which are available on the Company’s website www.globalcordbloodcorporation.com/en_US/.
In the event that the Court dispenses with the requirement to hold an EGM, shareholders of the Company will still be afforded
sufficient opportunity to raise any queries or concerns in relation to the Third Fee Report. In this regard, the JPLs invite any shareholders to submit enquiries by email to GCBCJPLs@uk.gt.com by no later than 28 August 2026.
Yours faithfully,
for and on behalf of
Global Cord Blood Corporation (In Provisional Liquidation)
/s/ John Royle
John Royle
Joint Provisional Liquidator of the Company by
Order of the Grand Court of the Cayman Islands
|
|
Grant Thornton Specialist Services (Cayman) Ltd 2
|